Cite
HARVARD Citation
Abrams, S. et al. (2018). Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in biological regulation. pp. 16-34. [Online].